Technologies improve pharmacy services
As pharmacists search for ways to serve patients more effectively, technology is becoming increasingly important.
Key Points
As pharmacists search for ways to serve their patients more effectively, the role of technology becomes increasingly important. Below are some products and applications that are helping pharmacists offer patients the best quality of care.
The new version of PharmASSIST SmartCabinet incorporates a high-resolution touch-screen display, a tuck-away keyboard and mouse drawer, and 46 independently operating tablet-and-capsule dispensers that count prescriptions simultaneously. The automated prescription-dispensing system has a large-volume-dispenser capacity that reduces replenishment frequency and streamlines the replenishment process, enabling pharmacies to maintain a perpetual inventory of each drug in their systems. It also features unique onsite dispenser calibration and locked, computer-controlled hopper doors.
This browser-based product allows LTC facilities to order new medications, refill prescriptions, add or update patient information, print refill reports, view delivery sheets, and receive medication orders from a Web browser.
In addition, the technology provides nurses at the LTC facility with a variety of clinical tools, such as applications allowing them to check for drug-drug interactions or to view geriatric precautions. And an updated WebConnect administrative function enables pharmacies to maintain specific data for the facility. (800-231-7776/ http://www.qs1.com/)
The system also eliminates problems associated with blister packs. ( http://www.insiterx.com/)
Socioeconomic Disparities Persisted Alongside Improving Vaccination Rates In US Over 11-Year Period
April 16th 2024Findings indicating that socioeconomic disparities widened gaps in vaccination timeliness signal the need for increased efforts to promote timely vaccination among children from families with lower income and those without private insurance.
FDA Expands Tenofovir Alafenamide Indication to Treat HBV in Patients as Young as 6
March 28th 2024Tenofovir alafenamide was originally approved by the FDA in 2016 to treat adults with chronic HBV infection with compensated liver disease and in 2022 to treat pediatric patients aged 12 years and older.
